Feedback / Questions
leiolizumab (ALTB-268) - AltruBio
https://www.globenewswire.com/news-release/2024/05/21/2885505/0/en/AltruBio-Secures-up-to-225M-Oversubscribed-Series-B-Financing-to-Advance-the-Clinical-Development-of-Novel-Immune-Checkpoint-Enhancer-Program.html
May 21, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next